Form 4: DSS, Inc. Increases Stake in Impact Biomedical Inc.

DSS, Inc. reports an increase in its indirect ownership of Impact Biomedical Inc. common stock through recent transactions and subsidiary holdings.

Summary

• On September 18, 2024, DSS, Inc. indirectly acquired 1,000 shares of Impact Biomedical Inc. common stock at a price of $2.33 per share.
• Following this transaction, DSS, Inc.'s indirect beneficial ownership totals 58,800 shares through Sentinel Brokers Company, Inc., a majority-owned subsidiary.
• DSS, Inc. also indirectly owns 1,345,482 shares through DSS BioHealth Security, Inc., 166,600 shares through DSS Securities, Inc., and 166,600 shares through DSS BlockChain Security, Inc., all of which are wholly-owned subsidiaries.
• The filing indicates DSS, Inc. now indirectly owns a total of 1,737,482 shares of Impact Biomedical Inc. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition. The increase in ownership could be seen as slightly positive, but without further context, it's difficult to gauge the overall impact.

Positives

• DSS, Inc. increased its investment in Impact Biomedical Inc., signaling confidence in the company.
• The acquisition was made at $2.33 per share.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders and major shareholders, providing transparency to the market.

Key Dates

Keywords

Impact Biomedical Inc., DSS, Inc., beneficial ownership, common stock, acquisition, subsidiary, IBO, Sentinel Brokers Company, DSS BioHealth Security, DSS Securities, DSS BlockChain Security